Ikena Oncology, Vall d'Hebron Institute Partner on Biomarker Research

The research on resistance mechanisms and drug combinations could aid the development of Ikena's drugs targeting the Hippo and RAS pathways.

Related Keywords

Boston ,Massachusetts ,United States ,Hebron ,Israel General ,Israel ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Merck Keytruda ,Bristol Myers Squibb Opdivo ,Jeffrey Ecsedy ,Josep Tabernero ,Hebron Institute Of Oncology , ,Ikena Oncology ,Hebron Institute ,Bristol Myers Squibb ,